Deerfield Management Company committed $130 million over the next 10 years to support the new company, Amethyst Innovations, which will be wholly owned by Deerfield affiliates, according to a June 6 press release from Deerfield. The aim of the company is to partner with the health system to advance its research projects that focus on drug exploration and development.
The collaboration will lean on NYU Langone’s internal drug accelerator, Therapeutics Alliances, for creations.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
